Abstract 5653: Preclinical characterization of LUA004, a novel 5T4-targeting ADC with improved therapeutic window.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institution: Qilu Pharmaceutical Co., Ltd. (China)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148907929
